Ordenar

Buscar

01/01/2023 The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Maravilla-Herrera P., Merino M., Alfonso Zamora S., Balea Filgueiras J., Carrascosa Carrillo J.M., Delgado Sánchez O., Dolz Sinisterra F., García-Ruiz A., Herranz Pinto P., Manfredi A., Martínez Olmos J., Morales de los Ríos Luna P., Puig L., Ros S., Hidalgo-Vega Á.. The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain. Frontiers in Public Health. 2023; 11DOI:10.3389/fpubh.2023.1000776. PMID:36778548. IF:3.000(Q2/3D).
01/01/2023 The impact of achieving and maintaining near-complete or complete skin clearance on patient quality of life in moderate-to-severe psoriasis
Ryan C., Puig L., Zema C., Thompson E.H.Z., Yang M., Wu E., Bensimon A., Huang X., Joshi A.D., Elewski B.. The impact of achieving and maintaining near-complete or complete skin clearance on patient quality of life in moderate-to-severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023; 88(1)DOI:10.1016/j.jaad.2021.12.032. PMID:34954285. IF:12.800(Q1/1D).
01/01/2023 Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain
Artime E., Serra E., Mert C., Díaz-Cerezo S., Huete T., Hernández-Subirá I., Lledo-Bryant L., Sicras-Mainar A.. Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain. Actas Dermo-Sifiliograficas. 2023; 114(1)DOI:10.1016/j.ad.2022.08.025. PMID:36368579. IF:(Q/D).
01/01/2023 Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial
Strober B., Paul C., Blauvelt A., Thaçi D., Puig L., Lebwohl M., White K., Vanvoorden V., Deherder D., Gomez N.N., Eyerich K.. Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023; 89(3)DOI:10.1016/j.jaad.2023.04.063. PMID:37182701. IF:12.800(Q1/1D).
01/01/2023 Genetic and Epigenetic Mechanisms of Psoriasis
Mateu-Arrom L., Puig L.. Genetic and Epigenetic Mechanisms of Psoriasis. Genes. 2023; 14(8)DOI:10.3390/genes14081619. PMID:37628670. IF:2.800(Q2/5D).
01/01/2023 The biological basis of disease recurrence in psoriasis
Carmona-Rocha E., Puig L.. The biological basis of disease recurrence in psoriasis. Italian Journal of Dermatology and Venereology. 2023; 158(4)DOI:10.23736/S2784-8671.23.07583-7. PMID:37404193. IF:1.800(Q3/6D).
01/01/2023 Diversity in the clinical presentation of generalized pustular psoriasis (GPP): A series of case vignettes from around the world
Choon S.E., Elewski B.E., Fujita H., Geng S., van de Kerkhof P., Mburu S., Puig L., Romiti R., Venturini M.. Diversity in the clinical presentation of generalized pustular psoriasis (GPP): A series of case vignettes from around the world. EXPERIMENTAL DERMATOLOGY. 2023; 32(8)DOI:10.1111/exd.14794. PMID:36999936. IF:3.500(Q1/3D).
01/01/2023 Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study
Marti-Marti I., Podlipnik S., Cañueto J., Ferrándiz-Pulido C., Deza G., Sanmartín O., Jaka A., Beà-Ardèbol S., Botella-Estrada R., Redondo P., Turrión-Merino L., Ruiz-Salas V., Masferrer E., Yébenes M., Sánchez-Schmidt J.-M., Gracia-Darder I., Altemir-Vidal A., Aguayo-Ortiz R.S., Becerril S., Bodet-Castillo D., Leal L., Fuente M.J., Moreno-Arrones O.M., Abril-Pérez C., Tomás-Velázquez A., Sandoval-Clavijo A., Toll A.. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023; 89(1)DOI:10.1016/j.jaad.2023.02.048. PMID:36907554. IF:12.800(Q1/1D).
01/01/2023 External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort
Van Straalen K.R., Tzellos T., Alavi A., Benhadou F., Cuenca-Barrales C., Daxhelet M., Daoud M., Efthymiou O., Giamarellos-Bourboulis E.J., Guillem P., Gulliver W., Jemec G.B.E., Katoulis A., Koenig A., Lazaridou E., Lowes M.A., Marzano A.V., Matusiak L., Molina-Leyva A., Moltrasio C., Pinter A., Potenza C., Prens E.P., Romaní J., Saunte D.M., Sayed C., Skroza N., Stergianou D., Szepietowski J.C., Trigoni A., Vilarrasa E., Kyrgidis A., Zouboulis C.C., Van Der Zee H.H.. External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort. DERMATOLOGY. 2023; 239(3)DOI:10.1159/000528968. PMID:36630943. IF:3.000(Q2/4D).
01/01/2023 Chronic prurigo: Insufficient disease control in spite of high healthcare usage
Pereira M.P., Weisshaar E., Halvorsen J.A., Wallengren J., Legat F.J., Garcovich S., Savk E., Reich A., Bozek A., Lvov A., Bobko S., Metz M., Streit M., Misery L., Brenaut E., Serra-Baldrich E., Gonçalo M., Szepietowski J.C., Augustin M., Nau T., Zeidler C., Ständer S.. Chronic prurigo: Insufficient disease control in spite of high healthcare usage. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(6)DOI:10.1111/jdv.18903. PMID:36682045. IF:8.500(Q1/1D).
01/01/2023 [Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts [Abordaje común del paciente con psoriasis y riesgo de esteatosis hepática metabólica: recomendaciones de un grupo de expertos multidisciplinar]
Carrascosa J.M., Vilarrasa E., Belinchón I., Herranz P., Crespo J., Guimerá F., Olveira A.. [Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts [Abordaje común del paciente con psoriasis y riesgo de esteatosis hepática metabólica: recomendaciones de un grupo de expertos multidisciplinar]. Actas Dermo-Sifiliograficas. 2023; 114(5)DOI:10.1016/j.ad.2023.04.013. PMID:37068635. IF:(Q/D).
01/01/2023 Skin cancer special issue in Skin Health and Disease
Yélamos O., Geller S., Tokez S.. Skin cancer special issue in Skin Health and Disease. Skin Health And Disease. 2023; 3(2)DOI:10.1002/ski2.224. PMID:37013119. IF:(Q/D).
01/01/2023 [Translated article] BAP1-inactivated Melanocytic Tumor: Dermoscopic Features to Aid Diagnosis [Tumor melanocítico inactivado a BAP1: claves para su diagnóstico dermatoscópico]
Fustà-Novell X., García-Herrera A., Yélamos O.. [Translated article] BAP1-inactivated Melanocytic Tumor: Dermoscopic Features to Aid Diagnosis [Tumor melanocítico inactivado a BAP1: claves para su diagnóstico dermatoscópico]. Actas Dermo-Sifiliograficas. 2023; 114(2)DOI:10.1016/j.ad.2022.11.008. PMID:36464005. IF:(Q/D).
01/01/2023 The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease
Olveira A., Augustin S., Benlloch S., Ampuero J., Suárez-Pérez J.A., Armesto S., Vilarrasa E., Belinchón-Romero I., Herranz P., Crespo J., Guimerá F., Gómez-Labrador L., Martín V., Carrascosa J.M.. The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life-Basel. 2023; 13(2)DOI:10.3390/life13020419. PMID:36836776. IF:3.200(Q1/3D).
01/01/2023 The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study
Rivera-Díaz R., Pozo T., Alfageme F., Díaz Ley B., Osorio G.F., Chico R., Vilarrasa E., Silvente C., Ciudad Blanco C., Romaní J., Martorell A., Fernández P., Romero Ferreiro C., Molina Leyva A.. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study. Actas Dermo-Sifiliograficas. 2023; 114(9)DOI:10.1016/j.ad.2023.06.013. PMID:37331620. IF:(Q/D).
01/01/2023 Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results
Pereyra-Rodriguez J.J., Herranz P., Figueras-Nart I., Perez B., Elosua M., Munera-Campos M., Melgosa-Ramos J., Zaragoza V., Silvestre J.F., Campos-Domínguez M., Guilabert A., Miquel J., Alcantara-Luna S., de la Cueva P., Serra-Baldrich E., Armario-Hita J.C.. Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(3)DOI:10.18176/jiaci.0831. PMID:35671128. IF:6.700(Q1/2D).
01/01/2023 Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians
Berna-Rico E., ABBAD-JAIME DE ARAGON C., Garcia-Aparicio Á., Palacios-Martinez D., Ballester-Martínez A., Carrascosa J.-M., DE LA CUEVA P., Anton C., Azcarraga-Llobet C., Garcia-Mouronte E., DE NICOLAS-RUANES B., Puig L., Jaen P., Mehta N.N., Gelfand J.M., Gonzalez-Cantero Á.. Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians. ACTA DERMATO-VENEREOLOGICA. 2023; 103DOI:10.2340/actadv.v103.5087. PMID:36987537. IF:3.500(Q1/3D).
01/01/2023 Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study.
Abarzua-Araya A, Bañuls J, Cabo H, Carrera C, Gamo R, González S, Jaimes N, Navarrete-Dechent C, Pérez Anker J, Roldán-Marín R, Segura S, Yélamos O, Puig S, Malvehy J. Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study.. Actas Dermo-Sifiliograficas. 2023; 115(3)DOI:10.1016/j.ad.2023.10.014. PMID:37890615. IF:(Q/D).
01/01/2023 Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain.
Artime E, Serra E, Mert C, Díaz-Cerezo S, Huete T, Hernández-Subirá I, Lledo-Bryant L, Sicras-Mainar A. Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain.. Actas Dermo-Sifiliograficas. 2023; 114(1)DOI:10.1016/j.ad.2022.08.015. PMID:36030827. IF:(Q/D).
01/01/2023 Tratamiento comparativo de lesiones mucocutáneas en pacientes con telangiectasia hemorrágica hereditaria con láser dual secuencial de colorante pulsado y neodimio: itrio-aluminio-granate versus neodimio: itrio-aluminio-granate solo: un estudio controlado aleatorizado doble ciego con evaluación de la calidad de vida
Cubiró X., Garcia-Melendo C., Morales-Munera C.E., Riera-Mestre A., Torres-Iglesias R., Villanueva B., Puig L., Baselga E.. Tratamiento comparativo de lesiones mucocutáneas en pacientes con telangiectasia hemorrágica hereditaria con láser dual secuencial de colorante pulsado y neodimio: itrio-aluminio-granate versus neodimio: itrio-aluminio-granate solo: un estudio controlado aleatorizado doble ciego con evaluación de la calidad de vida. Actas Dermo-Sifiliograficas. 2023; 115(3)DOI:10.1016/j.ad.2023.10.017. PMID:37913989. IF:(Q/D).
01/01/2023 Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782)
Navarro-Compán V., Puig L., Vidal S., Ramírez J., Llamas-Velasco M., Fernández-Carballido C., Almodóvar R., Pinto J.A., Galíndez-Aguirregoikoa E., Zarco P., Joven B., Gratacós J., Juanola X., Blanco R., Arias-Santiago S., Sanz J.S., Queiro R., Cañete J.D.. Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases(Front. Immunol., (2023), 14, (1191782), 10.3389/fimmu.2023.1191782). Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1332177. PMID:. IF:(Q/D).
01/01/2023 Quality of Life and Post-Surgical Complications in Patients on Chronic Antiplatelet Therapy with Proximal Femur Fracture: 12-Month Follow-Up after Implementing a Strategy to Shorten the Time to Surgery
Merchán-Galvis A., Anaya R., Rodriguez M., Llorca J., Castejón M., Gil J.M., Millan A., Estepa V., Cardona E., Garcia-Sanchez Y., Ruiz A., Martinez-Zapata M.J.. Quality of Life and Post-Surgical Complications in Patients on Chronic Antiplatelet Therapy with Proximal Femur Fracture: 12-Month Follow-Up after Implementing a Strategy to Shorten the Time to Surgery. Journal of Clinical Medicine. 2023; 12(3)DOI:10.3390/jcm12031130. PMID:36769778. IF:3.000(Q1/2D).
01/01/2023 Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II)
Llau J.V., Aldecoa C., Guasch E., Marco P., Marcos-Neira P., Paniagua P., Páramo J.A., Quintana M., Rodríguez-Martorell F.J., Serrano A.. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II). Revista Espanola De Anestesiologia Y Reanimacion. 2023; 70(7)DOI:10.1016/j.redar.2023.05.001. PMID:. IF:(Q/D).
01/01/2023 Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II)
Llau J.V., Aldecoa C., Guasch E., Marco P., Marcos-Neira P., Paniagua P., Páramo J.A., Quintana M., Rodríguez-Martorell F.J., Serrano A.. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II). Medicina Intensiva. 2023; 47(8)DOI:10.1016/j.medin.2023.03.007. PMID:. IF:(Q/D).
01/01/2023 To bulge or not to bulge: Rectus abdominis functional reconstruction after soft tissue sarcoma resection
Fernández-Garrido M., Torrano L., González López J., Masia J., Sisternas Hernández L., D'Guilio Arevalo G., Zamora Alarcón P.. To bulge or not to bulge: Rectus abdominis functional reconstruction after soft tissue sarcoma resection. Journal of Plastic Reconstructive and Aesthetic Surgery. 2023; 78DOI:10.1016/j.bjps.2022.11.051. PMID:36736105. IF:2.000(Q2/4D).
01/01/2023 Corrigendum to “The extended SCIP flap: An anatomical and clinical study of a new SCIP flap design”
Fernandez-Garrido M., Nunez-Villaveiran T., Zamora P., Masia J., Leon X.. Corrigendum to “The extended SCIP flap: An anatomical and clinical study of a new SCIP flap design”. Journal of Plastic Reconstructive and Aesthetic Surgery. 2023; 82DOI:10.1016/j.bjps.2023.04.064. PMID:37149911. IF:2.000(Q2/4D).
01/01/2023 Complications: How to Reduce and Manage
Masià J., Pomata C.D.. Complications: How to Reduce and Manage. Prepectoral Breast Reconstruction: Current Trends And Techniques. 2023; DOI:10.1007/978-3-031-15590-1_17. PMID:. IF:(Q/D).
01/01/2023 How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey
Guven, S, Colecchia, M, Oltulu, P, Bonfante, G, Enikeev, D, Esen, H, Herrmann, T, Lusuardi, L, Micali, S, Somani, B, Skolarikos, A, Breda, A, Liatsikos, E, Redorta, JP, Gozen, AS. How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey. WORLD JOURNAL OF UROLOGY. 2023; 41(10)DOI:10.1007/s00345-022-04022-2. PMID:35567624. IF:2.800(Q2/3D).
01/01/2023 The DEpth of Endoscopic Perforation scale to assess intraoperative perforations during transurethral resection of bladder tumor: subgroup analysis of a randomized controlled trial
Breda, A, Gallioli, A, Diana, P, Fontana, M, Territo, A, Gaya, JM, Rodriguez-Faba, O, Huguet, J, Piana, A, Verri, P, Baboudjian, M, Aumatell, J, Algaba, F, Palou, J. The DEpth of Endoscopic Perforation scale to assess intraoperative perforations during transurethral resection of bladder tumor: subgroup analysis of a randomized controlled trial. WORLD JOURNAL OF UROLOGY. 2023; 41(10)DOI:10.1007/s00345-022-04052-w. PMID:35665840. IF:2.800(Q2/3D).
01/01/2023 Energy source comparison in en-bloc resection of bladder tumors: subanalysis of a single-center prospective randomized study
Diana, P, Gallioli, A, Fontana, M, Territo, A, Bravo, A, Piana, A, Baboudjian, M, Gavrilov, P, Rodriguez-Faba, O, Gaya, JM, Algaba, F, Palou, J, Breda, A. Energy source comparison in en-bloc resection of bladder tumors: subanalysis of a single-center prospective randomized study. WORLD JOURNAL OF UROLOGY. 2023; 41(10)DOI:10.1007/s00345-022-04042-y. PMID:35639159. IF:2.800(Q2/3D).
01/01/2023 Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy
Katayama S., Pradere B., Grossman N.C., Potretzke A.M., Boorjian S.A., Ghoreifi A., Daneshmand S., Djaladat H., Sfakianos J.P., Mari A., Khene, ZE, D'Andrea D., Hayakawa N., Breda A., Fontana M., Fujita K., Antonelli A., van Doeveren T., Steinbach C., Mori K., Laukhtina E., Roupret, M, Margulis V., Karakiewicz P.I., Araki M., Compérat E., Nasu Y., Shariat S.F.. Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy. INTERNATIONAL JOURNAL OF UROLOGY. 2023; 30(1)DOI:10.1111/iju.15061. PMID:36349904. IF:1.800(Q3/6D).
01/01/2023 Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series
Korkes F., Timoteo F., Baccaglini W., Glina F., Faba O.R., Redorta, JP, Glina S.. Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series. UROLOGIA INTERNATIONALIS. 2023; 107(1)DOI:10.1159/000524578. PMID:36382647. IF:1.500(Q3/7D).
01/01/2023 Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort
Marra, G, Soria, F, Peretti, F, Oderda, M, Dariane, C, Timsit, MO, Branchereau, J, Hedli, O, Mesnard, B, Tilki, D, Olsburgh, J, Kulkarni, M, Kasivisvanathan, V, Lebacle, C, Rodriguez-Faba, O, Breda, A, Soeterik, T, Gandaglia, G, Todeschini, P, Biancone, L, Gontero, P. Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort. Cancers. 2023; 15(1)DOI:10.3390/cancers15010189. PMID:36612184. IF:4.500(Q1/3D).
01/01/2023 Reduced- vs full-dose BCG in bladder cancer: a systematic review and meta-analysis
Verri P., Baboudjian M., Diana P., Gallioli A., Territo A., Gaya J.M., Huguet J., Rodriguez-Faba O., Palou J., Breda A.. Reduced- vs full-dose BCG in bladder cancer: a systematic review and meta-analysis. Actas Urologicas Espanolas. 2023; 47(1)DOI:10.1016/j.acuro.2022.06.001. PMID:37078844. IF:1.200(Q3/8D).
01/01/2023 The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery
Bravi C.A., Rosiello G., Mazzone E., Minervini A., Mari A., Di Maida F., Bensalah K., Peyronnet B., Khene Z.-E., Schiavina R., Bianchi L., Mottrie A., De Naeyer G., Antonelli A., Furlan M., Rha K.H., Almujalhem A., Derweesh I., Bradshaw A., Kaouk J., Sawczyn G., Bertolo R., Breda A., Montorsi F., Capitanio U., Larcher A.. The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery. European Urology Open Science. 2023; 49DOI:10.1016/j.euros.2022.12.017. PMID:36874602. IF:3.200(Q1/2D).
01/01/2023 Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial
Angulo J.C., Álvarez-Ossorio J.L., Domínguez-Escrig J.L., Moyano J.L., Sousa A., Fernández J.M., Gómez-Veiga F., Unda M., Carballido J., Carrero V., Fernandez-Aparicio T., García de Jalón Á., Solsona E., Inman B., Palou J.. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial. European Urology Oncology. 2023; 6(1)DOI:10.1016/j.euo.2022.10.008. PMID:36435738. IF:8.300(Q1/1D).
01/01/2023 Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis
Crocerossa F., Autorino R., Derweesh I., Carbonara U., Cantiello F., Damiano R., Rubio-Briones J., Roupret M., Breda A., Volpe A., Mir M.C., European Section of Urologic-Oncology (ESOU) of European Association of Urology. Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis. Minerva Urology And Nephrology. 2023; 75(1)DOI:10.23736/S2724-6051.22.04881-9. PMID:36094386. IF:4.900(Q1/2D).
01/01/2023 Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomes
Del Giudice F., Kim W., Li S., DE Berardinis E., Sciarra A., Salciccia S., Ferro M., Autorino R., Pandolfo S.D., Crocetto F., Galfano A., Dell'oglio P., Cacciamani G.E., Pradere B., Laukhtina E., D'Andrea D., Belladelli F., Krajewski W., Mari A., Minervini A., Gallioli A., Amparore D., Checcucci E., Fiori C., Porpiglia F., Morgantini L., Crivellaro S., Chung B.I.. Management of the incidental adrenal mass, continued surveillance versus surgical excision: analysis of US claims data on contemporary socio-demographic predictors and perioperative outcomes. Minerva Urology And Nephrology. 2023; 75(1)DOI:10.23736/S2724-6051.22.05073-X. PMID:36197701. IF:4.900(Q1/2D).
01/01/2023 Preliminary evaluation of infrared imaging for real-time graft reperfusion assessment during kidney transplant: an ESUT-YAUWP project
Veneziano D., Basile G., Cignoli D., Cozzupoli P., Sgrò E., Gomez Rivas J., Dourado A., Okhunov Z., Somani B., Territo A., Cacciamani G., Breda A.. Preliminary evaluation of infrared imaging for real-time graft reperfusion assessment during kidney transplant: an ESUT-YAUWP project. Minerva Urology And Nephrology. 2023; 75(1)DOI:10.23736/S2724-6051.22.05119-9. PMID:36282547. IF:4.900(Q1/2D).
01/01/2023 Implementing a Checklist for Transurethral Resection of Bladder Tumor to Standardize Outcome Reporting: When High-quality Resection Could Influence Oncological Outcomes
Diana P., Baboudjian M., Gallioli A., Territo A., Fontanet S., Izquierdo P., Uleri A., Verri P., Rodriguez-Faba Ó., Gaya J.M., Sanguedolce F., Palou J., Breda A.. Implementing a Checklist for Transurethral Resection of Bladder Tumor to Standardize Outcome Reporting: When High-quality Resection Could Influence Oncological Outcomes. European Urology Open Science. 2023; 48DOI:10.1016/j.euros.2022.09.025. PMID:36588772. IF:3.200(Q1/2D).